Cite
HARVARD Citation
Neuzillet, C. et al. (n.d.). 2352 Sunitinib as second-line treatment in patients with advanced intrahepatic cholangiocarcinoma: Final results of the SUN-CK phase II trial from GERCOR IRC. European journal of cancer. pp. S452-. [Online].